These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 29980170)

  • 21. Assessment of Lean Patients with Non-alcoholic Fatty Liver Disease in a Middle Income Country; Prevalence and Its Association with Metabolic Disorders: A Cross-sectional Study.
    Naderian M; Kolahdoozan S; Sharifi AS; Garmaroudi G; Yaseri M; Poustchi H; Sohrabpour AA
    Arch Iran Med; 2017 Apr; 20(4):211-217. PubMed ID: 28412824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association of metabolic syndrome, insulin resistance and non-alcoholic fatty liver disease in overweight/obese children.
    El-Koofy NM; Anwar GM; El-Raziky MS; El-Hennawy AM; El-Mougy FM; El-Karaksy HM; Hassanin FM; Helmy HM
    Saudi J Gastroenterol; 2012; 18(1):44-9. PubMed ID: 22249092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic syndrome and gallstone disease.
    Chen LY; Qiao QH; Zhang SC; Chen YH; Chao GQ; Fang LZ
    World J Gastroenterol; 2012 Aug; 18(31):4215-20. PubMed ID: 22919256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence, clinical characteristics, risk factors, and indicators for lean Chinese adults with nonalcoholic fatty liver disease.
    Zeng J; Yang RX; Sun C; Pan Q; Zhang RN; Chen GY; Hu Y; Fan JG
    World J Gastroenterol; 2020 Apr; 26(15):1792-1804. PubMed ID: 32351294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of neck circumference as an easy and reliable predictor for non-alcoholic fatty liver disease.
    Salmanroghani H; Salmanroghani R; Nourian M; Khayarn K; Lahmi F; Iravani S
    Turk J Gastroenterol; 2019 Feb; 30(2):163-170. PubMed ID: 30541716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systematic review with meta-analysis: risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients.
    Sookoian S; Pirola CJ
    Aliment Pharmacol Ther; 2017 Jul; 46(2):85-95. PubMed ID: 28464369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-alcoholic fatty liver disease and its associated risk factors in Brazilian postmenopausal women.
    Bruno Ade S; Rodrigues MH; Alvares MC; Nahas-Neto J; Nahas EA
    Climacteric; 2014 Aug; 17(4):465-71. PubMed ID: 24517420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of non-alcoholic fatty liver disease (NAFLD) among children with obesity.
    Mohamed RZ; Jalaludin MY; Anuar Zaini A
    J Pediatr Endocrinol Metab; 2020 Feb; 33(2):247-253. PubMed ID: 31926095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Higher serum uric acid to HDL-cholesterol ratio is associated with onset of non-alcoholic fatty liver disease in a non-obese Chinese population with normal blood lipid levels.
    Zhu W; Liang A; Shi P; Yuan S; Zhu Y; Fu J; Zheng T; Wen Z; Wu X
    BMC Gastroenterol; 2022 Apr; 22(1):196. PubMed ID: 35448944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IS HOMEOSTASIS MODEL ASSESSMENT FOR INSULIN RESISTANCE >2.5 A DISTINGUISHED CRITERIA FOR METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE IDENTIFICATION?
    Barreto BFM; Punaro GR; Elias MC; Parise ER
    Arq Gastroenterol; 2022; 59(3):402-407. PubMed ID: 36102439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sex and age differences in the association of fatty liver index-defined non-alcoholic fatty liver disease with cardiometabolic risk factors: a cross-sectional study.
    Fresneda S; Abbate M; Busquets-Cortés C; López-González A; Fuster-Parra P; Bennasar-Veny M; Yáñez AM
    Biol Sex Differ; 2022 Nov; 13(1):64. PubMed ID: 36333736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of non-alcoholic fatty liver disease in women with polycystic ovary syndrome and its correlation with metabolic syndrome.
    Romanowski MD; Parolin MB; Freitas AC; Piazza MJ; Basso J; Urbanetz AA
    Arq Gastroenterol; 2015; 52(2):117-23. PubMed ID: 26039829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Characteristics and Metabolic Profiles of Non-Alcoholic Fatty Liver Disease (NAFLD) in Lean Patients and Their Comparison with Obese and Overweight NAFLD.
    Chakrabarty M; Jha AN; Sharma DJ
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Cardiovascular Risk Factors and Metabolic Syndrome with non-alcoholic and alcoholic fatty liver disease: a retrospective analysis.
    Han AL
    BMC Endocr Disord; 2021 May; 21(1):91. PubMed ID: 33933056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of reciprocal causality between non-alcoholic fatty liver disease and metabolic syndrome by a simplified Bayesian network in a Chinese population.
    Zhang Y; Zhang T; Zhang C; Tang F; Zhong N; Li H; Song X; Lin H; Liu Y; Xue F
    BMJ Open; 2015 Sep; 5(9):e008204. PubMed ID: 26395497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of and predictive factors for nonalcoholic fatty liver disease in Sudanese individuals with type 2 diabetes: Is metabolic syndrome the culprit?
    Almobarak AO; Barakat S; Suliman EA; Elmadhoun WM; Mohamed NA; Abobaker IO; Noor SK; Bushara SO; Ahmed MH
    Arab J Gastroenterol; 2015 Jun; 16(2):54-8. PubMed ID: 26174761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease.
    Motamed N; Sohrabi M; Ajdarkosh H; Hemmasi G; Maadi M; Sayeedian FS; Pirzad R; Abedi K; Aghapour S; Fallahnezhad M; Zamani F
    World J Gastroenterol; 2016 Mar; 22(10):3023-30. PubMed ID: 26973398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of uric acid levels with components of metabolic syndrome and non-alcoholic fatty liver disease in overweight or obese children and adolescents.
    Cardoso AS; Gonzaga NC; Medeiros CC; Carvalho DF
    J Pediatr (Rio J); 2013; 89(4):412-8. PubMed ID: 23791233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Triglycerides Mediate the Influence of Body Mass Index on Non-Alcoholic Fatty Liver Disease in a Non-Obese Chinese Population with Normal Low-Density Lipoprotein Cholesterol Levels.
    Han X; Kong J; Zhang H; Zhao Y; Zheng Y; Wei C
    Obes Facts; 2024; 17(2):191-200. PubMed ID: 38266508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Analysis of influencing factors and causes of death in elderly residents with non-alcoholic fatty liver disease].
    Xu JY; Shao Y; Lu XL; Deng J; Li XL; Shi HT
    Zhonghua Gan Zang Bing Za Zhi; 2019 Mar; 27(3):204-209. PubMed ID: 30929337
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.